Introduction: Osteoarthritis (OA) is a degenerative joint condition characterized by chronic pain and the need for pain management. Locally...
Array
(
[id_prestablog_news] => 2565
[id_shop] => 1
[date] => 2026-01-01 00:00:00
[date_modification] => 2026-01-01 00:00:00
[langues] => ["1","2"]
[actif] => 1
[slide] => 0
[url_redirect] =>
[average_rating] =>
[number_rating] =>
[author_id] => 1
[featured] => 0
[ishero] => 0
[prim_key] => 4998
[id_lang] => 2
[title] => Inhibiting nociceptor endocytosis reduces MIA-induced osteoarthritic pain behavi
[paragraph] => Inhibiting nociceptor endocytosis reduces MIA-induced osteoarthritic pain behavior
[content] => Authors
Aubrey J. Cooper, Jessica S. Tabman, Raider Rodriguez, Arin Bhattacharjee
Lab
Cognition and Behaviour; European Molecular Biology Laboratory (EMBL); Berkeley; Vienna BioCenter
Journal
bioRxiv
Abstract
Introduction: Osteoarthritis (OA) is a degenerative joint condition characterized by chronic pain and the need for pain management. Locally targeting the endocytotic AP2 complex in nociceptors presents a potential strategy for providing sustained pain relief in individuals with OA. Objective: We investigated whether pain behavior associated with OA can be mitigated by genetically silencing the AP2alpha2 subunit of the AP2 complex in nociceptors and by pharmacologically inhibiting the AP2 complex through the intraarticular administration of a small lipidated decoy peptide. Method: Monoiodoacetate (MIA) was employed to induce knee joint OA in mice and rats. Pain behavior was assessed using dynamic weight-bearing and von Frey filaments. Upon confirmation of established OA pain behavior, in vivo AP2alpha2 genetic knockdown in mice was achieved through sciatic nerve transfection of a targeting AP2alpha2 short hairpin RNA (shRNA). To pharmacologically target endocytosis, a single intraarticular injection of peptide was administered into the arthritic knee of rats. The injection contained either the AP2 inhibitor peptide or a scrambled peptide control. Results: Pain behavior was significantly reduced after both genetic and pharmacological disruption of AP2-driven endocytosis. Animals treated with the Ap2 inhibitor peptide exhibited reduced pain behavior throughout the 28-day assay period. Following the completion of behavioral testing, arthritic knee joints and contralateral healthy knee joints were subsequently collected to assess the impact of the treatment on disease progression. Micro-computed tomography analysis revealed a preservation of bone volume in the arthritic joints that received the AP2 inhibitor peptide treatment, in contrast to the scrambled peptide group. Conclusion: These findings demonstrate that the inhibition of nociceptor endocytosis by a small lipidated peptide presents a promising approach to provide sustained relief from joint pain in individuals with arthritis.
Keywords/Topics
chronic pain; pain management; sustained pain relief; pain behavior; mice; rats; established oa pain behavior; behavioral testing; joint pain; inhibiting nociceptor endocytosis
[meta_description] =>
[meta_keywords] => https://www.biorxiv.org/content/10.64898/2026.08.21.746311.abstract
[meta_title] =>
[link_rewrite] => Inhibiting-nociceptor-endocytosis-reduces-MIA-induced-osteoarthritic-pain-behavior
[actif_langue] => 1
[read] => 19
[count_comments] => 0
[id] => 2565
[categories] => Array
(
[70] => Array
(
[id_prestablog_categorie] => 70
[title] => Arthrite & Arthrose
[link_rewrite] => Arthrite-Arthrose
)
[2] => Array
(
[id_prestablog_categorie] => 2
[title] => Publications
[link_rewrite] => publications
)
)
[authors] =>
[paragraph_crop] => Inhibiting nociceptor endocytosis reduces MIA-induced osteoarthritic pain behavior
[link_for_unique] => 1
[products_liaison] => Array
(
[1216] => Array
(
[name] => Distribution Pondérale Dynamique 2.0
[description_short] => Un système permettant l'analyse de la posture des animaux par la répartition du poids sur chacune des 4 pattes. Le DWB est un test unique dans l'étude de nombreux modèles de douleurs, principalement non évoquée , neuropathique ou encore inflammatoire ainsi que pour les études sur l'osthéoarthrite et divers affections du SNC.
Le nouvelle version DWB2 intègre une nouvelle interface logiciel plus simple avec gestion des listes d'animaux ainsi que de nouveaux algorithmes d'analyse automatique de la posture.


[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://bioseb.com/fr/douleur-spontanee-deficit-de-posture/1216-dynamic-weight-bearing-20.html
)
[1860] => Array
(
[name] => Von Frey Électronique 5 avec caméra intégrée
[description_short] =>
En tant que version électronique du classique esthésiomètre à filaments de Von Frey, la dernière évolution de l’instrument électronique Von Frey de Bioseb, conçu pour déterminer le seuil de sensibilité mécanique chez les rongeurs (rats et souris) par stimulation sous la patte, est un outil indispensable pour vos recherches sur l’hyperalgésie et l’allodynie. En mesurant et en enregistrant la force à laquelle l’animal présente un réflexe de retrait de la patte, il est possible d’étudier les pathologies liées à la réponse sensorielle ainsi qu’à l’hyper- ou l’hypoesthésie.
L'EVF5 intègre une caméra embarquée au niveau de la zone de stimulation et fonctionne avec un nouveau logiciel dédié révolutionnaire


[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://bioseb.com/fr/douleur-allodyniehyperalgesie-mecanique/1860-electronic-von-frey-5-with-embedded-camera.html
)
)
)
1 En lire plus